• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化患者门静脉压力与结直肠血管病变的关系

Relationship of portal pressure and colorectal vasculopathy in patients with cirrhosis.

作者信息

Sugano S, Nishio M, Makino H, Suzuki T

机构信息

Department of Internal Medicine, Saiseikai Wakakusa Hospital, Yokohama, Japan.

出版信息

Dig Dis Sci. 1999 Jan;44(1):149-54. doi: 10.1023/a:1026670604551.

DOI:10.1023/a:1026670604551
PMID:9952236
Abstract

We studied the relationship between portal pressure and colorectal mucosal vascular lesions in cirrhotics and the effectiveness of drug therapy in treating these lesions. Colonoscopy and hepatic venous pressure gradient (HVPG) studies were performed in 21 cirrhotics. Oral spironolactone plus transdermal nitroglycerin were given to patients who had diffuse mucosal cherry-red spots and/or rectal varices. The colonoscopy and HVPG determinations were repeated after four weeks. Colonoscopic findings included vascular ectasias in 13 patients (62%), diffuse cherry-red spots in the rectum in five patients (24%), and rectal varices in eight patients (38%). Overall, colorectal mucosal vascular lesions were found in 16 cirrhotics (76%). These findings were not found in 21 age- and sex-matched noncirrhotic controls. Vascular ectasias appeared without relationship to the HVPG. Patients with diffuse cherry-red spots (N = 5, 22.4+/-3.4 mm Hg) had a significantly higher HVPG than those without (N = 16, 16.6+/-3.3 mm Hg, P < 0.01). However, no significant difference was found in HVPG between patients with rectal varices (N = 8, 19.4+/-4.6 mm Hg) and patients without rectal varices (N = 13, 17.2+/-3.8 mm Hg). After four weeks of drug therapy, diffuse cherry-red spots became less obvious when the HVPG decreased more than 20%. Rectal varices did not change their appearance with HVPG reduction. We found that colorectal vascular lesions are common in cirrhotics. Diffuse cherry-red spots are probably dependent on elevated portal pressure, but vascular ectasias and rectal varices are not related to the degree of portal pressure. Chronic drug therapy with reduction of portal pressure improves colonoscopic findings such as diffuse cherry-red spots.

摘要

我们研究了肝硬化患者门静脉压力与结直肠黏膜血管病变之间的关系以及药物治疗这些病变的有效性。对21例肝硬化患者进行了结肠镜检查和肝静脉压力梯度(HVPG)研究。对有弥漫性黏膜樱桃红点和/或直肠静脉曲张的患者给予口服螺内酯加经皮硝酸甘油治疗。四周后重复进行结肠镜检查和HVPG测定。结肠镜检查结果包括13例患者(62%)有血管扩张,5例患者(24%)直肠有弥漫性樱桃红点,8例患者(38%)有直肠静脉曲张。总体而言,16例肝硬化患者(76%)发现有结直肠黏膜血管病变。在21例年龄和性别匹配的非肝硬化对照者中未发现这些表现。血管扩张的出现与HVPG无关。有弥漫性樱桃红点的患者(N = 5,22.4±3.4 mmHg)的HVPG显著高于无弥漫性樱桃红点的患者(N = 16,16.6±3.3 mmHg,P < 0.01)。然而,有直肠静脉曲张的患者(N = 8,19.4±4.6 mmHg)与无直肠静脉曲张的患者(N = 13,17.2±3.8 mmHg)之间的HVPG未发现显著差异。药物治疗四周后,当HVPG下降超过20%时,弥漫性樱桃红点变得不那么明显。直肠静脉曲张的外观不会随HVPG降低而改变。我们发现结直肠血管病变在肝硬化患者中很常见。弥漫性樱桃红点可能与门静脉压力升高有关,但血管扩张和直肠静脉曲张与门静脉压力程度无关。降低门静脉压力的慢性药物治疗可改善结肠镜检查结果,如弥漫性樱桃红点。

相似文献

1
Relationship of portal pressure and colorectal vasculopathy in patients with cirrhosis.肝硬化患者门静脉压力与结直肠血管病变的关系
Dig Dis Sci. 1999 Jan;44(1):149-54. doi: 10.1023/a:1026670604551.
2
Chronic splanchnic hemodynamic effects of low-dose transdermal nitroglycerin versus low-dose transdermal nitroglycerin plus spironolactone in patients with cirrhosis.
Dig Dis Sci. 1997 Mar;42(3):529-35. doi: 10.1023/a:1012993224326.
3
Hepatic venous pressure gradient in cirrhosis: correlation with the size of varices, bleeding, ascites, and child's status.肝硬化患者的肝静脉压力梯度:与静脉曲张大小、出血、腹水及Child分级的相关性
Dig Dis Sci. 2006 Dec;51(12):2264-9. doi: 10.1007/s10620-006-9310-2. Epub 2006 Nov 1.
4
Portal hypertensive colopathy in patients with cirrhosis.肝硬化患者的门静脉高压性结肠病
Scand J Gastroenterol. 1996 May;31(5):490-4. doi: 10.3109/00365529609006770.
5
Evaluation of rectal mucosal hemodynamics in patients with liver cirrhosis using reflectance spectrophotometry.使用反射分光光度法评估肝硬化患者的直肠黏膜血流动力学。
Am J Gastroenterol. 1997 Jun;92(6):1022-5.
6
Application of a standardised protocol for hepatic venous pressure gradient measurement improves quality of readings and facilitates reduction of variceal bleeding in cirrhotics.应用标准化的肝静脉压力梯度测量方案可提高读数质量,并有助于减少肝硬化患者的静脉曲张出血。
Singapore Med J. 2016 Mar;57(3):132-7. doi: 10.11622/smedj.2016054.
7
Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertension.抗病毒治疗可降低 HBeAg 阴性慢性乙型肝炎和显著门静脉高压所致肝硬化患者的门静脉压力。
J Hepatol. 2009 Sep;51(3):468-74. doi: 10.1016/j.jhep.2009.05.031. Epub 2009 Jul 3.
8
Portal hypertensive colopathy: endoscopic findings and the relation to portal pressure.门静脉高压性结肠病:内镜检查结果及其与门静脉压力的关系
Intern Med. 1995 Mar;34(3):153-7. doi: 10.2169/internalmedicine.34.153.
9
Small intestinal edema had the strongest correlation with portal venous pressure amongst capsule endoscopy findings.胶囊内镜检查结果中,小肠水肿与门静脉压力相关性最强。
Digestion. 2012;86(1):48-54. doi: 10.1159/000338180. Epub 2012 Jun 15.
10
Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertension.病毒抑制对丙型肝炎肝硬化伴门静脉高压患者肝静脉压力梯度的影响。
J Viral Hepat. 2017 Oct;24(10):823-831. doi: 10.1111/jvh.12706. Epub 2017 Apr 10.

引用本文的文献

1
Spontaneous bleeding or thrombosis in cirrhosis: What should be feared the most?肝硬化中的自发性出血或血栓形成:最应担心的是什么?
World J Hepatol. 2015 Jul 18;7(14):1818-27. doi: 10.4254/wjh.v7.i14.1818.
2
Portal hypertensive colopathy is associated with portal hypertension severity in cirrhotic patients.门脉高压性结肠病与肝硬化患者的门脉高压严重程度相关。
World J Gastroenterol. 2009 Oct 14;15(38):4781-7. doi: 10.3748/wjg.15.4781.

本文引用的文献

1
Chronic splanchnic hemodynamic effects of spironolactone with unrestricted sodium diet in patients with compensated cirrhosis.螺内酯对钠摄入不受限的代偿期肝硬化患者的慢性内脏血流动力学影响
Dig Dis Sci. 1998 Apr;43(4):893-7. doi: 10.1023/a:1018851022316.
2
Chronic splanchnic hemodynamic effects of low-dose transdermal nitroglycerin versus low-dose transdermal nitroglycerin plus spironolactone in patients with cirrhosis.
Dig Dis Sci. 1997 Mar;42(3):529-35. doi: 10.1023/a:1012993224326.
3
Hepatic venous pressure measurement: an old test as a new prognostic marker in cirrhosis?肝静脉压力测量:一项古老的检测作为肝硬化新的预后标志物?
Hepatology. 1997 Jan;25(1):245-8. doi: 10.1053/jhep.1997.v25.ajhep0250245.
4
Portal hypertensive colopathy in patients with cirrhosis.肝硬化患者的门静脉高压性结肠病
Scand J Gastroenterol. 1996 May;31(5):490-4. doi: 10.3109/00365529609006770.
5
Isosorbide-5-mononitrate versus propranolol in the prevention of first bleeding in cirrhosis.异山梨醇-5-单硝酸酯与普萘洛尔预防肝硬化首次出血的对比研究
Gastroenterology. 1993 May;104(5):1460-5. doi: 10.1016/0016-5085(93)90356-h.
6
Effects of low-sodium diet and spironolactone on portal pressure in patients with compensated cirrhosis.低钠饮食和螺内酯对代偿期肝硬化患者门静脉压力的影响。
Hepatology. 1994 May;19(5):1095-9. doi: 10.1002/hep.1840190506.
7
Portal hypertensive colopathy: endoscopic findings and the relation to portal pressure.门静脉高压性结肠病:内镜检查结果及其与门静脉压力的关系
Intern Med. 1995 Mar;34(3):153-7. doi: 10.2169/internalmedicine.34.153.
8
The prevalence and spectrum of colonic lesions in patients with cirrhotic and noncirrhotic portal hypertension.肝硬化和非肝硬化门静脉高压患者结肠病变的患病率及范围
Hepatology. 1995 May;21(5):1226-31.
9
Oral administration of nipradilol and the acute and chronic splanchnic hemodynamic effects of a new beta-blocker with nitrovasodilating properties in patients with liver cirrhosis.硝苯洛尔口服给药及一种具有硝基血管舒张特性的新型β受体阻滞剂对肝硬化患者急性和慢性内脏血流动力学的影响。
Am J Gastroenterol. 1995 May;90(5):788-93.
10
Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis.肝硬化患者药物治疗后门静脉压力反应与复发性静脉曲张出血风险之间的关系
Lancet. 1995 Oct 21;346(8982):1056-9. doi: 10.1016/s0140-6736(95)91740-3.